Value of circulating N-terminal pro-brain natriuretic peptide for prognosis of cardiovascular events in patients with non-Hodgkin lymphoma in remission

Value of circulating N-terminal pro-brain natriuretic peptide for prognosis of cardiovascular events in patients with non-Hodgkin lymphoma in remission

Purpose – to evaluate the prognostic value of circulating NT-proBNP for cardiovascular events, cumulative survival in patients with non-Hodgkin lymphoma in remission. Materials and methods. Eighty two subjects with non-Hodgkin lymphoma in full or partial remission were enrolled in the study. Obse...

Full description

Bibliographic Details
Main Author:	B. B. Samura
Format:	Article
Language:	English
Published:	Zaporozhye State Medical University 2015-12-01
Series:	Patologìâ
Subjects:	NT-proBNP Non-Hodgkin Lymphoma Survival Prognosis
Online Access:	http://pat.zsmu.edu.ua/article/view/55590/54469

Similar Items

Predictive value of circulating N-terminal pro-brain natriuretic peptide in patients after treatment of Hodgkin lymphoma (a 3-year prospective study)
by: B. B. Samura
Published: (2017-12-01)

Circulative biomarkers as predictors of cardiovascular events in patients after treatment of Hodgkin lymphoma
by: B. B. Samura
Published: (2017-12-01)

Clinical correlation between N-terminal pro-b-type natriuretic peptide and angiographic coronary atherosclerosis
by: Demóstenes G.L. Ribeiro, et al.
Published: (2014-06-01)

Using N-terminal pro-B-type natriuretic peptide to diagnose cardiac abnormalities in children with dyspneaen with dyspnea
by: Zakaria Mukalla, et al.
Published: (2017-06-01)

N-terminal-pro-brain natriuretic peptide is decreased in insulin dependent gestational diabetes mellitus: a prospective cohort trial
by: Gottsauner-Wolf Michael, et al.
Published: (2011-04-01)

N‐terminal pro brain natriuretic peptide reference values in community‐dwelling older adults
by: Ulrike Braisch, et al.
Published: (2022-06-01)

The prognostic value of the plasma N-terminal pro-brain natriuretic peptide level on all-cause death and major cardiovascular events in a community-based population
by: Zhu Q, et al.
Published: (2016-02-01)

N-TerminalPro-B-TypeNatriuretic Peptide For Detecting Early Cardiac Dysfunction in Patients with Thyroid Dysfunction
by: Makbule Ulusoy, et al.
Published: (2013-09-01)

Prognosis Implication of N-Terminal Pro-B-Type Natriuretic Peptide in Adult Patients With Acute Myocarditis
by: Yan Zhao, et al.
Published: (2022-03-01)

N-terminal-pro-brain natriuretic peptide, but not brain natriuretic peptide, is increased in patients with severe obesity
by: F. Fernandes, et al.
Published: (2007-02-01)

Correlation of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) with radiographic features of congestion in chest CT scan of patients with COVID-19
by: Naghmeh Ziaie, et al.
Published: (2023-07-01)

N-terminal proBrain Natriuretic Peptide as Indicator of Left Ventricle Hypertrophy In Hypertensive Patients Compared with Left Ventricle Mass Index in Echocardiography
by: Mohammad Ariful Munir, et al.
Published: (2013-06-01)

RETRACTED: N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE (NT-proBNP) IN STAGE 1 AND STAGE 2 HYPERTENSION PATIENTS
by: Supriati Wila Djami
Published: (2019-10-01)

Effect of feline characteristics on plasma N‐terminal‐prohormone B‐type natriuretic peptide concentration and comparison of a point‐of‐care test and an ELISA test
by: Sofia Hanås, et al.
Published: (2020-05-01)

N-Terminal Prohormone of Brain Natriuretic Peptide but not C-Terminal Pre-Pro Vasopressin (Copeptin) Level is Associated with the Response to Antihypertensive Therapy in Haemodialysis Patients
by: Katarzyna Wyskida, et al.
Published: (2017-11-01)

N-terminal prohormone brain natriuretic peptide (NT-proBNP) as a noninvasive marker for restrictive syndromes
by: C. Mady, et al.
Published: (2008-08-01)

N-Terminal Pro B-Type Natriuretic Peptide's Usefulness for Paroxysmal Atrial Fibrillation Detection Among Populations Carrying Cardiovascular Risk Factors
by: Elena Palà, et al.
Published: (2019-11-01)

The predictive capacity and additional prognostic power of N-terminal pro-B-type natriuretic peptide in Chinese elderly with chronic heart failure
by: Fu S, et al.
Published: (2015-01-01)

Prognostic Significance of the N-Terminal Pro-B-Type Natriuretic Peptide in Lung Transplant Candidates on the Waiting List
by: Shimon Izhakian, et al.
Published: (2022-08-01)

N‐Terminal pro‐B‐type natriuretic peptide and stroke risk across a spectrum of cerebrovascular disease: The REasons for Geographic and Racial Differences in Stroke cohort
by: Kara K. Landry, et al.
Published: (2020-07-01)

Optimal cut points of N-terminal of the prohormone brain natriuretic peptide (NT-proBNP) in patients with COVID-19
by: Mohammad Chehrazi, et al.
Published: (2022-03-01)

N‐terminal pro brain natriuretic peptide eliminates the prognostic effect of atrial fibrillation in patients with chronic heart failure
by: Johannes Schnorbach, et al.
Published: (2019-08-01)

The effects of central arterial pressure and autonomic dysfunction on elevations in N-terminal pro-B-type natriuretic peptide (NT-proBNP) in men with diabetes
by: S. Bunce, et al.
Published: (2008-04-01)

Diagnostic value of NT–PRO BNP in cardiogenic and non cardiogenic pleural effusions
by: Mohamed E. Abdalla, et al.
Published: (2012-07-01)

Relationship of diabetes, heart failure, and N‐terminal pro‐B‐type natriuretic peptide with cardiovascular outcomes in patients with atrial fibrillation
by: Felix Hofer, et al.
Published: (2022-08-01)

N-Terminal Pro-brain Natriuretic Peptide Is Associated With Hemorrhagic Transformation and Poor Outcomes in Patients With Stroke Treated With Intravenous Thrombolysis
by: Ke-Jia Zhang, et al.
Published: (2021-11-01)

Point‐of‐care N‐terminal pro B‐type natriuretic peptide assay to screen apparently healthy cats for cardiac disease in general practice
by: Ta‐Li Lu, et al.
Published: (2021-07-01)

Higher BNP/NT‐pro BNP levels stratify prognosis equally well in patients with and without heart failure: a meta‐analysis
by: Stefanie Hendricks, et al.
Published: (2022-10-01)

Atrial Fibrillation, thromboembolic risk, and the potential role of the natriuretic peptides, a focus on BNP and NT-proBNP – A narrative review
by: Brian Kerr, et al.
Published: (2022-12-01)

Influence of preoperative serum N-terminal pro-brain type natriuretic peptide on the postoperative outcome and survival rates of coronary artery bypass patients
by: Thomas Schachner, et al.
Published: (2010-01-01)

Investigating the Role of Brain Natriuretic Peptide (BNP) and N-Terminal-proBNP in Thrombosis and Acute Ischemic Stroke Etiology
by: Rosanna Rossi, et al.
Published: (2024-03-01)

Age-adjusted plasma N-terminal pro-brain natriuretic peptide level in Kawasaki disease
by: Heul Jun, et al.
Published: (2016-07-01)

Assessment of the impact of different N terminal pro brain natriuretic peptide thresholds on echocardiography services
by: Eric Yii, et al.
Published: (2022-02-01)

N‐Terminal Pro‐B‐Type Natriuretic Peptide as a Biomarker for the Severity and Outcomes With COVID‐19 in a Nationwide Hospitalized Cohort
by: Christian O’Donnell, et al.
Published: (2021-12-01)

Urinary N‐terminal pro‐brain natriuretic peptide: prognostic value in patients with acute chest pain
by: Stefanie Reynen, et al.
Published: (2021-06-01)

Prognostic value of N-terminal Pro–B-Type natriuretic peptide in patients with intermediate coronary lesions
by: Chenxi Song, et al.
Published: (2022-07-01)

Performance of the Abbott Architect Immuno-Chemiluminometric NT-proBNP Assay
by: Chin-Shern Lau, et al.
Published: (2022-05-01)

Plasma Glial Fibrillary Acidic Protein and N-Terminal Pro B-Type Natriuretic Peptide: Potential Biomarkers to Differentiate Ischemic and Hemorrhagic Stroke
by: Eunhee Han, et al.
Published: (2023-08-01)

C-reactive protein and N-terminal pro-brain natriuretic peptide discrepancy: a differentiation of adenoviral pharyngoconjunctival fever from Kawasaki disease
by: Jung Eun Choi, et al.
Published: (2018-01-01)

Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide and High-Sensitivity C-Reactive Protein in Patients With Previous Myocardial Infarction
by: Ye-Xuan Cao, et al.
Published: (2022-02-01)